The contribution of SOCS1 signaling to melanoma immune evasion was shown by the prophylactic s.c. inoculation of a low number of B16shR-SOCS1 viable cells, that was able to protect against rechallenge with B16F10-Nex2 melanoma cells in a syngeneic model. The gene discussed is SOCS1; the disease is melanoma.